{
    "medicine_id": "76e414c738e473e7ec8a71c30e6dbf88c7e23c85",
    "platform_id": "DB04854",
    "metadata": {
        "name": "Adenuric 80 mg Tablet film coated",
        "composition": "80 mg Febuxostat",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of hyperuricemia in patients with gout",
            "contraindications": {
                "disease": "The FDA adverse event reporting system database AERS indicated potential signals of febuxostat associated cardiovascular thromboembolic events AERS is not capable of establishing the causal link and detecting the true frequency of an adverse event associated with a drug The positive IC value found in this study merits continued surveillance and assessment of cardiovascular thromboembolic events associated with Febuxostat",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Febuxostat ULORIC is a novel xanthine oxidase dehydrogenase XO XDH inhibitor being developed by Teijin TAP Pharmaceuticals and Ipsen for the treatment of gout The currently available XO inhibitor allopurinol has been associated with serious instances of severe hypersensitivity in some cases leading to fatalities There is some suggestion that febuxostat is less prone to excacerbate systemic inflammatory events in animal studies",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00201",
                        "description": "The serum concentration of the active metabolites of Caffeine can be increased when Caffeine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The serum concentration of the active metabolites of Theophylline can be increased when Theophylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "The serum concentration of the active metabolites of Dyphylline can be increased when Dyphylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The serum concentration of the active metabolites of Pentoxifylline can be increased when Pentoxifylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The serum concentration of the active metabolites of Aminophylline can be increased when Aminophylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The serum concentration of the active metabolites of Oxtriphylline can be increased when Oxtriphylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The serum concentration of the active metabolites of Theobromine can be increased when Theobromine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The serum concentration of the active metabolites of Fenethylline can be increased when Fenethylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The serum concentration of the active metabolites of 8 azaguanine can be increased when 8 azaguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "The serum concentration of the active metabolites of 7 9 Dimethylguanine can be increased when 7 9 Dimethylguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The serum concentration of the active metabolites of Xanthine can be increased when Xanthine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "The serum concentration of the active metabolites of 7 Deazaguanine can be increased when 7 Deazaguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "The serum concentration of the active metabolites of Guanine can be increased when Guanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The serum concentration of the active metabolites of 9 Methylguanine can be increased when 9 Methylguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The serum concentration of the active metabolites of Peldesine can be increased when Peldesine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The serum concentration of the active metabolites of Hypoxanthine can be increased when Hypoxanthine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The serum concentration of the active metabolites of 9 Deazaguanine can be increased when 9 Deazaguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The serum concentration of the active metabolites of Propentofylline can be increased when Propentofylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "The serum concentration of the active metabolites of Valomaciclovir can be increased when Valomaciclovir is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "The serum concentration of the active metabolites of 3 isobutyl 1 methyl 7H xanthine can be increased when 3 isobutyl 1 methyl 7H xanthine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "The serum concentration of the active metabolites of Uric acid can be increased when Uric acid is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The serum concentration of the active metabolites of Doxofylline can be increased when Doxofylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The serum concentration of the active metabolites of 6 O benzylguanine can be increased when 6 O benzylguanine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The serum concentration of the active metabolites of Lisofylline can be increased when Lisofylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The serum concentration of the active metabolites of Lobucavir can be increased when Lobucavir is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The serum concentration of the active metabolites of Cafedrine can be increased when Cafedrine is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The serum concentration of the active metabolites of Theodrenaline can be increased when Theodrenaline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The serum concentration of the active metabolites of Bamifylline can be increased when Bamifylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The serum concentration of the active metabolites of Proxyphylline can be increased when Proxyphylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The serum concentration of the active metabolites of Acefylline can be increased when Acefylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The serum concentration of the active metabolites of Etamiphylline can be increased when Etamiphylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The serum concentration of the active metabolites of Pentifylline can be increased when Pentifylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The serum concentration of the active metabolites of Bufylline can be increased when Bufylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The serum concentration of the active metabolites of Bromotheophylline can be increased when Bromotheophylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The serum concentration of the active metabolites of Furafylline can be increased when Furafylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The serum concentration of the active metabolites of 8 chlorotheophylline can be increased when 8 chlorotheophylline is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "The serum concentration of the active metabolites of PCS 499 can be increased when PCS 499 is used in combination with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "The serum concentration of Didanosine can be increased when it is combined with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The serum concentration of Mercaptopurine can be increased when it is combined with Febuxostat"
                    },
                    {
                        "drugbank-id": "DB09208",
                        "description": "The risk or severity of adverse effects can be increased when Febuxostat is combined with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Febuxostat can be decreased when used in combination with Cyclopenthiazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}